Japan Tobacco Inc. · TSE:2914
Japan Tobacco — Q1 2021 Earnings Presentation
9 slides from Japan Tobacco's earnings presentation, Apr 30, 2021
Slide 1: 2021 First-Quarter Results
2021 First-Quarter Results Naohiro Minami JT Group Chief Financial Officer *Please be reminded that the figures shown on these slides may differ from those shown in the financial statements as they are intended to facilitate the reader’s understanding of individual businesses. *For details of each t
Slide 2: Forward-Looking Statements
FORWARD-LOOKING STATEMENTS This presentation contains forward-looking statements. These statements appear in a number of places in this document and include statements regarding the intent, belief, or current and future expectations of our management with respect to our business, financial condition
Slide 3: 2021 First-Quarter Consolidated Results
2021 First-Quarter Consolidated Results Adjusted Operating Profit (AOP) at constant FX: +27.2％ vs. PY （JPY BN） Q1 2021 vs. PY • Driven by the strong business momentum of our tobacco businesses Reported • High growth rate in Q1 due to factors such as temporary stronger domestic volume in some high ma
Slide 4: Japanese-domestic tobacco business: Volume Performance and Financial Results
Japanese-domestic tobacco business : Volume Performance and Financial Results Industry volume Volume (BnU) Industry JT SoM/SoS • RMC: decreased due to higher RRP consumer applications, price hike and the impact from COVID-19 as well as natural decline 35.6 15.9 44.8％ Total Tobacco* • RRP: increased
Slide 5: International tobacco business: Volume Performance and Financial Results
International tobacco business: Volume Performance and Financial Results Topline performance Volume（BnU） Q1 2021 vs. PY • Strong share momentum, notably in our key markets, supported by: Total shipment volume 110.2 +5.8% • Stronger domestic volume mainly in the high margin markets of Taiwan and the
Slide 6: Pharmaceutical and Processed food businesses: Financial Results
Pharmaceutical and Processed food businesses: Financial Results Pharmaceutical Business • Revenue and AOP decreased, mainly due to lower overseas royalty income (JPY BN) Q1 2021 vs. PY Revenue 19.7 -5.2% Reference: Clinical development updates, received following approvals (March 23) • CORECTIM® Oin
Slide 7: Closing remarks
Closing remarks • Robust performance in Q1 2021 due to strong momentum in our tobacco businesses with some one-time favorable factors • Combustibles market share continued to grow Shareholders • RRP sales volume increased steadily in Japan, largest market for heated tobacco sticks • Launch of “Ploom
Slide 8: Definitions
<Definitions> Adjusted operating profit (AOP): Adjusted operating profit = operating profit + amortization cost of acquired intangibles arising from business acquisitions + adjusted items (income and costs)* * Adjusted items (income and costs) = impairment losses on goodwill ± restructuring income a
Slide 9: Definitions
<Definitions> Total tobacco industry volume: Industry volume in Japan market by number of sticks based on the internal (Japanese-domestic tobacco business) estimate. This includes cigarettes, little cigars, RRP and others RMC: Ready made cigarettes (Japanese-domestic tobacco business) RMC industry v